Clinical Trial

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

Study acronym: DECATEC
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated January 16, 2026 (before its estimated June 18, 2026 completion). Its status may not reflect the trial's current state.
Summary
Women suffering from endometriosis and/or adenomyosis may also suffer from infertility. GnRH agonist injection could improve implantation and therefore increase the pregnancy rate in these patients. This study was designed to evaluate effects of the additional of GnRH agonist (single or 2 doses) to the routine oestrogens and progestins use as support before Frozen Embryon Transfer as compared to oestrogens and progestins only.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2020-04-20; most recent amendment 2026-01-15.
Status change: Not Yet Recruiting → Recruiting 2021-06-15
Trial Details
NCT Number NCT04356664
Lead Sponsor Hopital Foch
Conditions Endometriosis, Adenomyosis, Infertility, Female
Enrollment 180 participants
Start Date 2021-03-18
Primary Completion 2026-06-18 (estimated)
Study Completion 2026-06-18 (estimated)
Updated on ClinicalTrials.gov 2026-01-16